Clark David Michael
Chief People Officer
Clark David Michael has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Apr 27, 2026.
On the most recent filing, Clark David Michael is listed as Chief People Officer at AMICUS THERAPEUTICS, INC. Inside the rolling window, Clark David Michael reported no open-market purchases and 4 open-market sales totaling $1.1M in FOLD. The largest disclosed transaction in the window is a sale of 25,642 FOLD shares on Dec 19, 2025, worth $363K.
Companies traded
Other insiders at FOLD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Clark David Michael made?
Clark David Michael has filed 6 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Clark David Michael trade?
Clark David Michael has filed SEC Form 4 disclosures for 1 company, including FOLD.
When was Clark David Michael's most recent SEC Form 4 filing?
Clark David Michael's most recent SEC Form 4 filing on Tracefour is dated Apr 27, 2026.
What is Clark David Michael's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Clark David Michael is listed as Chief People Officer.
What is Clark David Michael's total buy and sell value in the current window?
Inside the rolling retention window, Clark David Michael bought $0 and sold $1.1M based on SEC Form 4 filings.
What was Clark David Michael's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,642 FOLD shares on 2025-12-19, worth $363K, per SEC Form 4 filings.